A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.
Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the ... [4954 chars]